Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHFA on multivitamins

This article was originally published in The Tan Sheet

Executive Summary

The Canadian Health Food Association is using a recently published meta-analysis of multivitamin use and the prevention of birth defects to promote multivitamin compliance as a way to reduce healthcare costs, according to a Sept. 1 release from the trade group. "Research continues to show that multivitamins are a simple, cost-effective way to support improved immune function and help prevent chronic disease," CHFA President Valerie Bell says in the release. The study in the August Journal of Obstetrics & Gynecology of Canada finds use of folic-acid containing prenatal multivitamins was associated with a decreased risk for several congenital anomalies, not only neural tube defects, according to Y. Ingrid Goh, Department of Pharmaceutical Sciences, University of Toronto, Canada, et al. The authors suggest reconsidering the current approach of recommending only folic acid in light of their research. In May, a panel convened by NIH determined current data was "insufficient" to make a conclusive recommendation for or against the use of multivitamins in the prevention of chronic diseases (1"The Tan Sheet" May 22, 2006, p. 6)...
Advertisement

Related Content

More support for prenatal MVMs
More Multivitamin Research Needed To Show Disease Prevention – NIH Panel
More Multivitamin Research Needed To Show Disease Prevention – NIH Panel

Topics

Advertisement
UsernamePublicRestriction

Register

PS099733

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel